Acquisition of 85 % stake in Renalyx Health Systems Private Limited
Awaiting price reaction for this filing.
Lords Mark Industries Ltd has acquired an 85% equity stake in Renalyx Health Systems Private Limited, a Bengaluru-based med-tech company developing indigenous, AI-enabled smart hemodialysis systems. The deal was completed in August 2025 and Renalyx will function as the R&D arm of Lords Mark Industries. The acquisition is aimed at expanding into next-generation medical technologies focused on chronic kidney disease (CKD) and renal care solutions. It is not a related party transaction and no separate governmental or regulatory approvals were required. The move aligns with the government's 'Make in India' initiative to promote indigenous medical innovation.
This acquisition marks Lords Mark Industries' strategic entry into the healthcare/med-tech sector, potentially diversifying its revenue base and opening long-term growth opportunities in renal care. Shareholders may view this positively as it signals expansion into a high-growth segment, though execution and integration risks remain.